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Abstract
The present report deals with a multiple tract-tracing procedure in non-human primates enabling the simultaneous visualization of
 .  .retrogradely transported Fluoro-Gold FG and cholera toxin B subunit CTB in combination with anterogradely transported biotinylated
 .dextran amine BDA . Two issues have played key roles on the achievement of this reliable procedure: first, the recent development of a
commercial antiserum against FG that allows us to convert the original fluorescent signal of this dye in a permanent precipitate via
w  .standard peroxidase-anti-peroxidase methods; second, the introduction of the novel peroxidase substrate Vector VIP V-VIP , resulting
in a purple precipitate. The combination of these neuroanatomical tracers in one and the same histological section opens a possibility for
the permanent visualization of the convergence of inputs from a particular brain area onto identified, two different subsets of projection
cells of another area. Furthermore, this combination of three tracers emerges as a powerful technical tool for obtaining broad amounts of
complementary data regarding the monkey brain connectivity, thus significantly reducing the number of animals needed to complete a
particular study. q 1998 Elsevier Science B.V. All rights reserved.
Themes: Cell biology
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1. Type of research
1. Triple labeling studies.
2. Multiple axonal tracing combining anterograde and ret-
rograde tract-tracing methods.
3. Analysis of the convergence of one particular projection
onto two different types of projection neurons.
2. Time required
1. Surgery
fl Deep intracranial stereotaxic surgery in large mon-
 .keys Macaca fascicularis is very demanding re-
garding the time spent on it. Pre-surgical care in-
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cluding anesthesia and placement of the monkey in
the stereotaxic frame is about 1 h, immediately
followed by a ventriculography in order to find the
appropriate horizontal position of the head. This
latter procedure takes about 1 h more. The time
spent on tracer delivery varies depending on the
accuracy of the injections, each one of them moni-
tored under radiological control. Overall, the total
surgical procedure takes about 9 h to be completed,
plus another 2 or 3 h of post-surgical care until the
monkey shows full recovery.
2. Survival time
fl The survival time should be adjusted to the length of
the pathway being studied. In our experimental de-
sign, satisfactory labeling of long pathways for
example, from the caudate nucleus to the substantia
.nigra have been obtained with survival times of two
weeks.
3. Perfusionrfixation and sectioning
fl The total time spent on this procedure is approxi-
mately 1 h. Careful dissection of the brain takes 4 h.
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Cryoprotection of the tissue lasts about two days.
Sectioning of the entire brain for light microscopy is
done on a freezing microtome through an entire day
of work.
4. Staining
 .fl The biotinylated dextran amine BDA protocol is
completed in 4 h, to which 72 h have to be added to
 .complete both the cholera toxin CTB and the
 .Fluoro-Gold FG protocol. Additional processing of
the sections mounting on glass slides, dehydration
.and coverslipping means several more days.
5. Total estimation
fl Overall, this entire technical procedure requires al-
most one month to be fully completed, from the
beginning to the end.
3. Materials
The animals used in this study were male monkeys
 .Macaca fascicularis with a body weight ranging from
2500 to 3200 g. The animals were handled at all times
according to the Society for Neuroscience Policy on the
Use of Animals in Neuroscience Research. Animal han-
dling was conducted under supervision of the Ethical
Committee of the University of Navarra. Animals were
 .supplied by R.C. Hartelust Tilburg, The Netherlands .
1. Special equipment
fl Siemens Rx tube SR 90r20 FN. Germany.
fl Vertical glass capillary puller Narishige PB-7
fl Stereotaxic frame David Kopf model 1730. David
Kopf Instruments, Tujunga, CA.
fl Micromanipulator David Kopf model 1760-61.
fl Hamilton syringe 801-RNE 10 ml model H-0084804.
Hamilton, Reno, NV.
fl Perfusion peristaltic pump Watson–Marlow model
501S-170. Falmouth, Cornwall, England.
fl Surgical microscope Zeiss Power Supply 11. Ger-
many.
fl Freezing sliding microtome Microm model HM-400.
Germany.
fl Orbital shaker Janke and Kunkel model IKA vibrax
Vx1. Germany.
2. Chemicals and reagents
w  .fl Xilonibsa 10% of a solution of lidocaine . Labs.
Inibsa, 08029 Barcelona, Spain.
w  .fl Ketolar ketamine, 50 mgrml . Parke Davis,
Warner Lambert, Morris Plains, NJ.
w  .fl Dormicum Midazolam 5 mgrml . F. Hofmann-La
Roche, Basel, Switzerland.
 .fl Finadyne Flunixin meglumine . Schering-Plough,
Madrid, Spain.
w  .fl Ampicilina ampiciline 1 mg ref. 620583. Instituto
Llorente, Madrid, Spain.
w  .fl Omnigraph 330 X, 50 ml . Juste SAQF, Madrid,
Spain.
fl Biotinylated dextran amine BDA; dextran, biotin,
.10.000 MW, lysine fixable . Molecular Probes Eu-
rope, Leiden, The Netherlands.
fl Fluoro-Gold. Fluorochrome, Englewood, CO.
fl Cholera toxin B subunit ref. 104. List Biological
Laboratories, Campbell, CA.
fl ABC kit standard ref. PK-4000. Vector Labs,
Burlingame, CA.
fl Rabbit anti-FG ref. AB-153. Chemicon Interna-
tional, Temecula, CA.
fl Swine anti rabbit IgG ref. Z0195. Dakopatts ars,
Glostrup, Denmark.
fl Rabbit-PAP ref. Z0113. Dakopatts.
fl Goat anti-CTB ref. 703. List Biological.
fl Donkey anti-goat IgG ref. 03N09-181. Nordic Im-
munological Laboratories, Tilburg, The Netherlands.
fl Goat-PAP ref. 03N15-005. Nordic.
 .fl Albumine fraction V BSA ref. 1.12018 Merck,
Darmstadt, Germany.
X  .fl 3-3 diaminobenzidine DAB ref. D-5637. Sigma
Chemical, St. Louis, MO.
fl Nickel ammonium sulfate ref. 464545. Farmitalia
Carlo Erba, Milano, Italy.
w  .fl Vector VIP V-VIP ref. PK-4600. Vector.
fl Trizma 7-9w ref. T-1378. Sigma.
fl Entellanw ref. 1.07961. Merck, Darmstadt, Ger-
many.
 .Fig. 1. Composite plate showing several steps related to primate surgery and dissection of the brain. A shows the first ventriculography, done as an
 .assessment of the appropriate, horizontal position of the head. Once the needle is placed on the lateral ventricle of the right brain hemisphere arrow , a
 .  .volume of 0.3 ml of radiographic contrast was injected to fully delineate the ventricular system. B Higher magnification view taken from A in order to
better appreciate the ventricular system, the position of the needle, as well as the anatomical localization of both the anterior and posterior commissures. It
can be easily noticed that both commissures are not located within the same horizontal line, and hence being necessary to correct the position of the head.
 . C Ventriculography showing the position of the needle within the medial part of the left globus pallidus the second needle, just caudal to the one of the
.  .ventriculography . Once the plate has been carefully checked, BDA is injected through this needle. D Low-power magnification microphotograph
showing the BDA injection site in the medial part of the globus pallidus. This injection site corresponds to the ventriculography of the former picture.
Small arrows indicate three small patches of BDA-labeled fibers within the thalamus. An asterisk is placed in the third ventricle. Abbreviations: GPe:
 .external globus pallidus; GPi: internal globus pallidus; IC: internal capsule. E Dissection of the brain. Please note the craniotomy that can be seen in the
 .  .dorsal part of the skull, which corresponds to the one shown in C see arrows . The picture is taken to compare the relative sizes of the brain and the
 .  .skull. F Once the brain is removed from the skull, a total number of five blocks were cut from rostral to caudal blocks 1 to 5 , at approximate intervals
of 15 mm. Several basal ganglia nuclei can easily be appreciated in blocks 2 and 3.
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 .fl Dimethylsulphoxide DMSO f.a. ref. 131954. Pan-
reac, Barcelona, Spain.
4. Detailed procedure
4.1. Surgery
4.1.1. Anesthetic solution and post-surgical care
Preliminary anesthesia was induced by intramuscular
w  .injection of a solution of Ketolar 10 mgrkg . Surgical
anesthesia was achieved with an 1:1 mixture containing
w  . w  .Ketolar 10 mgrml and Dormicum 5 mgrkg , result-
ing in deep anesthesia for 2 to 3 h. Two additional doses of
this anesthetic solution were given throughout the surgical
procedure. Local anesthesia was induced with Xilonibsaw
immediately prior to the surgery. Once the surgery is
completed and prior to the monkey recovery, analgesia
was achieved by an intramuscular injection of 1 ml of
w  .Finadyne 5 mgrkg . This injection was repeated 24 and
48 h post-surgery. A similar schedule was also performed
for the application of antibiotics to prevent infections. The
w  .daily intramuscular injection of Ampicilina 0.5 mlrday
was administered through an entire week. During the
survival time, animals were kept under constant control in
single cages and fed with food and water ad libitum.
4.1.2. Ventriculography
Attempts to find the real brain size and the most
appropriate horizontal position of the head are crucial to
ensure the right target for tracer delivery. Accordingly, a
ventriculography was performed in the opposite brain
hemisphere. Each ventriculography consisted of the deliv-
 w .ery of 0.2 ml of Rx contrast Omnigraph 300 into the
frontal horn of the lateral ventricle to obtain a complete
filling of the ventricular system. The coordinates for the
lateral ventricle were taken 1 mm lateral from the sagittal
sinus. Once the Rx plate was developed, both the anterior
 .  .ac and posterior pc commissures were localized. The
ac–pc was measured and used as a reference for position-
ing the head parallel to the horizontal plane. The coordi-
nates for the different target areas were calculated accord-
ing the length of the ac–pc line. Additional help regarding
stereotaxic coordinates was taken from the atlas of Szabo
w xand Cowan 26 . These procedures are illustrated in Fig.
1A,B.
4.1.3. Tracer deli˝ery
All tracers were pressure-injected with a Hamilton sy-
 .ringe 0.2 ml each . FG was injected in the putamen as a
2% solution in 0.1 M cacodylate buffer, pH 7.3. CTB was
delivered in the ipsilateral caudate nucleus as a 2% solu-
 .tion in 0.1 M phosphate buffer PB , pH 6.0. Finally, BDA
was injected in the medial part of the ipsilateral globus
pallidus as a 10% solution in 0.01 M PB, pH 7.25.
Once each syringe was placed in the calculated target
area and before the tracer delivery, an additional ventricu-
lography was made to assess the accurate localization of
the needle. When the syringe was not placed into the right
target, it was necessary to correct the position of the
syringe, resulting in more additional ventriculographies,
until reaching the almost complete security of the appropri-
 .ate placement of each individual injection Fig. 1C .
4.2. Sur˝i˝al time
Survival time has to be adapted to the length of the
pathway being studied. There is little information available
on the detectability of BDA as a function of the survival
wtime. BDA has a wide range of survival time 5,12–
x14,18,19,31,34 . The BDA’s longest reported survival time
w xis seven weeks for squirrel monkeys 5 . In our case, two
weeks were enough to obtain a nice staining of the palli-
donigral pathway. Similar statements can be used when
considering FG and CTB survival times. FG has a wider
spectrum of survival time, ranging from two days to one
w xyear 1,16,17,22 – 24 . Tract-tracing with CTB
w x6,11,15,20,25,29,32 varies as a function of survival time.
 .Short survival times 24–48 h resulted in intense antero-
w xgrade labeling 2,28 , while longer survival times display a
tendency to enhance the reliability of CTB for retrograde
axonal tracing. The survival time used in the present
procedure resulted in intense retrograde labeling with CTB,
as well as a slight amount of CTB anterogradely labeled
fibers.
4.3. Perfusionr fixationrsectioning
The animals were re-anesthetized with an overdose of
10% chloral hydrate in distilled water and perfused tran-
scardially. The perfusates consisted on a Ringer saline
 .rinsing solution at body temperature , immediately fol-
lowed by 3000 ml of cold fixative containing 4% para-
formaldehyde, 0.1% glutaraldehyde and 0.2% saturated
picric acid in 0.125 M PB, pH 7.4. Subsequently, the
perfusion was continued by using 1000 ml of a cryoprotec-
tive solution containing 1% DMSO and 10% glycerin in
0.125 M PB, pH 7.4. After the perfusion, the skull was
 .opened and the brain removed Fig. 1E,F . Tissue blocks
 .1.5 cm thick were stored for 48 h in a cryoprotective
w xsolution 21 containing 2% DMSO and 20% glycerin in
0.1 M PB pH 7.4. Finally, frozen coronal sections 40 mm
.thick were obtained and collected in 0.125 M PB 0.125 M
pH 7.4.
4.4. Histology
 .Step 1: Wash the sections three times 10 min each in
w w  .0.05 M TBS-Tx, pH 8.0. 6.06 g Trizma Sigma q8.85
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 .g NaClq975 ml H Oq25 ml 20% Triton X-100 Sigma .2
Then add a few drops of 1 N HCl to reach the adequate
xpH .
Step 2: Incubation in ABC solution 90 min, room
.temperature . To prepare 1 ml of the ABC solution, add 8
 .ml of solution A avidin DH to 1 ml of 0.05 M TBS-Tx,
pH 8.0 and shake briefly. Then add 8 ml of solution B
 .biotinylated horseradish peroxidase H and shake for sev-
eral seconds. Please note than once the solution is pre-
pared, it is necessary to wait 30 min before use.
 .Step 3: Wash the sections twice 10 min each in 0.05
M TBS-Tx pH 8.0.
 .Step 4: Wash the sections twice 10 min each in 0.05
M TrisrHCl pH 8.0. 6.06 g Trizmaw q1000 ml H O.2
Then add a few drops of 1 N HCl to reach the final pH.
Step 5: Histochemical reaction. BDA stain with a
 .DAB–Ni solution 5 to 10 min, room temperature . 200
mg nickel ammonium sulfateq50 ml 0.05 M TrisrHCl
pH 8.0. When dissolved, add 7.5 mg of DAB and store in
the dark. Immediately before use, add 10 ml 30% H O .2 2
 .Step 6: Wash the sections three times 10 min each in
0.05 M TrisrHCl pH 8.0.
 .Step 7: Wash the sections three times 10 min each in
0.05 M TBS-Tx, pH 8.0.
Step 8: Incubation in a cocktail solution of primary
 .  .antisera 60 h, 48C . Goat anti-CTB List Biological and
 .rabbit anti-FG Chemicon are used at a dilution of 1:2000
in TBS-Tx, pH 8.0 containing 2% BSA.
 .Step 9: Wash the sections three times 10 min each in
0.05 M TBS-Tx, pH 8.0.
Step 10: Incubation in a cocktail solution of secondary
 .antisera 120 min, room temperature . Donkey anti-goat
 .  .Nordic and swine anti-rabbit Dako are used at a dilu-
tion of 1:50 in TBS-Tx, pH 8.0.
 .Step 11: Wash the sections three times 10 min each in
0.05 M TBS-Tx, pH 8.0.
Step 12: Incubation in a peroxidase complex raised in
 .goat goat-PAP; 90 min, room temperature . Goat-PAP
 .Nordic is used at a dilution of 1:600 in TBS-Tx, pH 8.0.
 .Step 13: Wash the sections twice 10 min each in 0.05
M TBS-Tx, pH 8.0.
 .Step 14: Wash the sections once 10 min in 0.05 M
TrisrHCl, pH 8.0.
Fig. 2. Scheme of the striatonigral connectivity and the use of the present
 .multiple tracing technique to visualize it. 1 Panel illustrating the connec-
tivity itself as shown by the involved neurons, as well as the related
 .nuclei, in which each tracer was delivered: BDA anterograde tracer was
 .injected in the medial part of the globus pallidus, CTB retrograde tracer
 .  .in the caudate nucleus, and FG retrograde tracer in the putamen. 2 The
first step comprised the detection of transported BDA using an ABC
solution, and then stained in bluerblack with DAB–Ni as a chromogen.
 .3 the second step consisted of the detection of the transported CTB via
 .a PAP procedure, brown-stained with DAB. 4 Finally, another PAP
procedure was conducted for the detection of the FG-containing neurons,
and the reaction was completed with the peroxidase substrate V-VIP
 .purple precipitate .
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 .Step 15: Wash the sections twice 10 min each in 0.05
M TrisrHCl, pH 7.6.
Step 16: Immunoreaction. CTB stain with a DAB solu-
 .tion 30–40 min, room temperature . 5 mg DABq10 ml
0.05 M TrisrHCl, pH 7.6. Store in the dark and filter.
Immediately before use, add 3.3 ml 30% H O .2 2
 .Step 17: Wash the sections twice 10 min each in 0.05
M TrisrHCl, pH 7.6.
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 .Step 18: Wash the sections once 10 min in 0.05 M
TrisrHCl, pH 8.0.
 .Step 19: Wash the sections twice 10 min each in 0.05
M TBS-Tx, pH 8.0.
Step 20: Incubation in a peroxidase–antiperoxidase
complex raised in rabbit rabbit-PAP; 90 min, room tem-
.  .perature . Rabbit-PAP Dako is used at a dilution of 1:600
in TBS-Tx, pH 8.0.
 .Step 21: Wash the sections twice 10 min each in 0.05
M TBS-Tx, pH 8.0.
 .Step 22: Wash the sections once 10 min in 0.05 M
TrisrHCl, pH 8.0.
 .Step 23: Wash the sections twice 10 min each in 0.05
M TrisrHCl, pH 7.6.
Step 24: Immunoreaction. Transported FG is stained
w x  .with a V-VIP solution 35 . 5–10 min, room temperature .
V-VIP peroxidase substrate is presented as a kit containing
four vials. In order to prepare 3.5 ml of the working
solution, one drop of each vial has to be used: 1 drop vial
Aq1 drop vial Bq1 drop vial Cq1 drop peroxidase
reagent in 3.5 ml 0.05 M TrisrHCl pH 7.6.
 .Step 25: Wash the sections three times 10 min each in
0.05 M TrisrHCl, pH 7.6.
 .Step 26: Mounting. 2 g gelatin Merck q1000 ml
 .warm 608C 0.05 M TrisrHCl, pH 7.6.
Step 27: Coverslipping. Once the sections were dried,
dehydration and clearing is achieved by using two rinsing
 .steps 4 min each in toluene. Finally, sections were
w  .coverslipped with Entellan Merck .
4.5. Safety requirements
 .a Animal handling: All the monkeys used in the
present study have been tested by the supplier for several
distinct kinds of infectious diseases, including TB, HSV-B,
SIV, salmonella, shigella and philovirus. Nevertheless,
animals were kept in single cages for a minimum of 40
days upon receipt and then tested again for TB, prior to
undergoing surgery. Throughout surgery, we strongly rec-
ommended the use of double pair of gloves and mask, plus
the standard safety precautions when dealing with experi-
mental animals.
 .b Chromogens: Two peroxidase substrates used in the
 .present study DAB and DAB–Ni are suspected carcino-
gens and need to be handled with care inside a fume hood.
V-VIP chromogen is presented by Vector Labs as a non-
w xcarcinogenic chromogen 2 , but due to the little informa-
tion provided by the supplier on the chemical composition
of this substrate, we recommended the use of the same
standard safety considerations for DAB handling.
 .c Solvents: Cacodylate buffer can be considered as a
poisonous solution and has to be handled with care.
5. Results
Animals received separate injections of BDA, CTB and
 .FG in different nuclei of the basal ganglia Fig. 2 . The
pallidonigral pathway is labeled after a BDA deposit in the
medial part of the globus pallidus. A subpopulation of
neurons of the substantia nigra, which project to the cau-
date nucleus, were identified by means of retrograde trans-
port of CTB, while another subpopulation of nigral cells
projecting to the putamen were retrogradely labeled after a
FG injection in the putamen. A moderate amount of CTB-
anterogradely labeled fibers can also be seen in the sub-
stantia nigra. Some CTB- and FG-labeled neurons can also
be appreciated in the contralateral substantia nigra.
The sensitive protocol reported here resulted in intense
labeling of three different structures in the substantia nigra,
simultaneously showing up anterogradely transported BDA
 .blue–black fibers , and retrogradely transported CTB and
 .  .FG brown and purple cells, respectively Fig. 3A . Higher
magnification can be used to disclose the fine morphologi-
cal details of the anterogradely labeled fibers and the
retrogradely labeled neurons within the areas in which the
labeled structures show a certain degree of overlapping
 .Fig. 3B,C .
Non-specific background staining has been kept to min-
imum levels, specially when considering that we were
dealing with triple staining procedures. In this regard, the
present combination of three tracers resulted in a slight
degree of background staining, similar to the one obtained
in other multiple combinations of tracers previously re-
w xported 13,14 .
6. Discussion
The focus of this report is to extend the use of multiple
tract-tracing protocols in the primate brain by showing that
three widely used neuroanatomical tracers can be simulta-
 .Fig. 3. Triple-stained section. A Low-power magnification photocomposition showing a coronal section of the primate brain through the substantia nigra.
The injected tracers were simultaneously detected in one and the same section according to a three-color paradigm. BDA fibers were black-stained using
DAB–Ni, CTB-containing neurons and fibers were stained in brown with DAB and somatopetally transported FG was stained in purple using V-VIP. Blue
arrows shows a large patch of BDA-containing fibers, while green arrows indicate anterogradely transported CTB. One can easily notice several distinct
 .  .patterns of distribution overlapping andror segregation for the types of projections being studied here. B and C Pictures taken at higher magnification
 .  .in order to better see the morphological details that can be observed by using this procedure. The arrows in B show a CTB-labeled fiber. C Illustrates
two well-defined populations of neurons. The purple arrow is showing a FG-positive cell, while the green arrow is pointing at a CTB-containing neuron.
 .  .Close appositions can also be seen between the BDA-labeled fibers and the FG-positive neurons small black arrow . Scale bar is 1 mm for A , 400 mm
 .  .for B , and 200 mm for C .
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neously and permanently detected in one and the same
w xsection, according to a three-color paradigm 13,14 . The
use of monkeys as experimental subjects is technically
very demanding, time-consuming and quite expensive.
Moreover, there is quite some social controversy in using
non-human primates in research. Accordingly, the possibil-
ity of simultaneous detection of three tracers resulted in
broad amounts of information about the way in which
three different kinds of projections interact each other, thus
allowing to reduce the number of animals needed to
complete a particular study.
6.1. Troubleshooting
6.1.1. The use of Fluoro-Gold in axonal tracing with
monkeys
There is some discrepancy regarding the use of FG for
tract-tracing studies in monkeys. It has been pointed out
that FG may produce variable results when this tracer is
w xused in non-human primates 22 , and the reasons for this
variability remains not understood. Only very little work
has been done using somatopetally transported FG in
w xmonkeys 8,9,27 . According to our experience, the best
results using FG have been obtained by dissolving the
tracer in 0.1 M cacodylate buffer, pH 7.3, as previously
w xreported elsewhere 24 . Dilutions of FG in other solvents
rather than cacodylate buffer, such as distilled or deionized
water, phosphate buffers or acetate buffers resulted in an
non-homogeneous solution that often precipitates, and this
may seriously compromise axonal uptake Please note that
FG is a complex mixture of several chemical compounds.
For more details regarding FG composition and axonal
w x.uptake, see Wessendorf 33 .
6.1.2. Sur˝i˝al time
As previously stated, survival time has to be adapted to
the length of the pathways being study. When considering
protocols aimed at the simultaneous detection of three
axonal tracers in one and the same section, it is mandatory
to choose three tracers that can afford a similar survival
time. In this regard, the three markers used in the present
 .combination BDA, CTB and FG allows a survival time
w xlarge enough 5,10,11,15,16,23 to be able to adjust the
survival time convenient for almost any kind of experi-
mental design in monkeys.
6.1.3. Application of antibodies to Fluoro-Gold
The somatopetally transported FG shows a relative
resistance to fading, a common problem to all fluoro-
probes. In order to avoid fading problems, photoconver-
 .sion of the dye in an stable diaminobenzidine DAB
reaction product can be obtained either via photo-oxidation
w xunder UV light 3,4 or by means of the application of
w xantibodies against FG 7,30 . Photoconverted FG resulted
in a permanent DAB reaction product that facilitates the
ultrastructural examination of the structures displaying
tracer. Photoconversion under UV light is partially limited
by the fact that only one marker can be photoconverted in
a single section, while the application of antiserum against
FG allows several combinations of this tracer either with
w xthe detection of neuroactive substances 7,30 , or with
w xother protocols commonly used for tract-tracing 13,14 .
As far as we know, two reliable antiserum against FG are
currently commercially available Chemicon ref. No. AB-
.153 and Biogenesis ref. No. 4512-4018 .
6.1.4. Special remarks regarding triple staining protocols
There are several issues that play key roles when trying
to obtain fine technical results using the three color
paradigm described in the present report.
 .a The main problem one may encounter when dealing
with the simultaneous detection of three markers is the
possible appearance of high degrees of non-specific back-
ground staining, which may hinder the results. The best
way to solve this kind of problem is to undergo a careful
control under the microscope of the progression of the
different reactions corresponding to each particular chro-
mogen. This procedure may enable to halt the reaction just
in time, before background staining begins to show up.
Otherwise, the existence of a slight degree of background
stain during the first incubation may enhance the non-
specific stain obtained in the second reaction, and both will
therefore have a kind of multiplying effect on the degree
of background stain one may find in the third final reac-
tion; thus sometimes almost impossible to clearly visualize
the three final colors corresponding to each particular
chromogen. Additionally, prolonged incubations in the
different chromogens solutions resulted in the appearance
of color mixing phenomena i.e., the tendency of a particu-
lar chromogen for taking the color corresponding to an-
.other peroxidase substrate . This particular phenomenon is
observed quite often in the areas displaying large amounts
 .of the reaction product for example, the injection sites .
 .b The strongest chromogen used in this procedure
obviously is the nickel-enhanced DAB substrate DAB–
.Ni . This substrate has been chosen to detect the BDA-
labeled fibers, according to a standard histochemistry by
using an ABC solution. In other words, there are no
antibodies involved in the BDA detection, so the degree of
non-specific background staining is kept to a minimum
during the first incubation. Accordingly, one would expect
higher amounts of background staining during the second
and the third incubations both are standard PAP proce-
.dures . In this regard, the use of 2% BSA as an agent for
binding non-specific tissue antibodies resulted in an evi-
dent improvement of the final staining quality. Separate
controls showed that the rabbit and the goat antisera did
not cross-react.
 .c The use of higher dilutions of the V-VIP substrate
as compared to the original guidelines provided by the
.supplier , resulted in a more handily substrate, so the way
in which the reaction progress is much slower, thus facili-
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tating to halt the reaction just in time, and hence avoiding
background staining, as well as the appearance of color
mixing phenomena. The resulting final purple precipitate is
unstable under standard ethanol treatments. Therefore,
toluene can be used as an alternative to ethanol for dehy-
dration procedures.
6.2. Alternati˝e protocols
This same multitracer study has been successfully used
to investigate basal ganglia circuits in rats. Moreover, the
three-color paradigm described in the present report allows
several other possibilities, such as the simultaneous detec-
tion of anterogradely transported BDA and PHA-L in
w xcombination with retrogradely transported FG 14 , or the
 .visualization of two tracers BDA and FG plus the im-
munocytochemical detection of the calcium binding pro-
w xteins parvalbumin or calbindin 13 . The use of the peroxi-
dase substrate V-VIP can be extended to the electron
microscopy, resulting in granular electron dense deposit.
This characteristic of the V-VIP substrate is very helpful in
the case of double pre-embedding protocols, first detecting
a particular antigen with DAB substrate, and then another
w xmarker by using V-VIP substrate 35 .
Another reliable option for the simultaneous detection
of three tracers can be achieved by using the fluorescence
microscope. FG is visible after UV-excitation; BDA can be
 .detected by red fluorescent carbocyanine 3 Cy3 -strepta-
vidin and CTB might be visualized by indirect immuno-
fluorescence based on goat anti-CTB and green fluorescent
Cy2-donkey anti-goat.
Finally, there are other chromogens currently available,
such as alkaline phosphatase, BDHC, TMB, etc., which
might be explored in order to design several other combi-
nations of multiple tract-tracing procedures.
7. Quick procedure
 .A Tracer delivery, survival time, perfusion, cryopro-
tection and sectioning.
 . B Incubation in the ABC solution 90 min, room
.temperature .
 .  .C DAB–Ni reaction 5–10 min, room temperature .
 .D Incubation in a cocktail of primary antiserum con-
taining 1:2000 goat anti-CTBq1:2000 rabbit anti-FG
 .60 h, 48C .
 .E Incubation in a cocktail of secondary antiserum
containing 1:50 donkey anti-goatq1:50 swine anti-rab-
 .bit 120 min, room temperature .
 .F Incubation in the tertiary antiserum 1:600 goat-PAP
 .90 min, room temperature .
 .  .G DAB reaction 20–40 min, room temperature .
 .H Incubation in the tertiary antiserum 1:600 rabbit-PAP
 .90 min, room temperature .
 .  .I V-VIP reaction 5–10 min, room temperature .
 .J Mount sections on gelatin, dehydrate via toluene and
coverslip with Entellanw.
8. Essential literature references
wOriginal papers: Refs. 5,7,11,13,14,18,19,22–
x25,30,31,35 .
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